about
PET/CT imaging in lung cancer: indications and findingsTransformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of originLayered superhydrophobic meshes for controlled drug releaseSpotlight on pembrolizumab in non-small cell lung cancer: the evidence to dateProposing Essential Medicines to Treat Cancer: Methodologies, Processes, and OutcomesmiR-141 and miR-200c as markers of overall survival in early stage non-small cell lung cancer adenocarcinomaPreclinical assessment of carboplatin treatment efficacy in lung cancer by 18F-ICMT-11-positron emission tomographySignificance of TP53 mutations as predictive markers of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer.TINAGL1 and B3GALNT1 are potential therapy target genes to suppress metastasis in non-small cell lung cancer.Proto-oncogene Wip1, a member of a new family of proliferative genes in NSCLC and its clinical significance.Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathwayActivating transcription factor 3 promotes malignance of lung cancer cells in vitroDown-regulation of miR-214 reverses erlotinib resistance in non-small-cell lung cancer through up-regulating LHX6 expression.Low-expression of TMEM100 is associated with poor prognosis in non-small-cell lung cancer.Receptor of activated protein C promotes metastasis and correlates with clinical outcome in lung adenocarcinoma.Long noncoding RNA ROR regulates chemoresistance in docetaxel-resistant lung adenocarcinoma cells via epithelial mesenchymal transition pathway.Non-coding RNAs as emerging regulators of epithelial to mesenchymal transition in non-small cell lung cancer.Targeting CCR2 with its antagonist suppresses viability, motility and invasion by downregulating MMP-9 expression in non-small cell lung cancer cellsElevated CD147 expression is associated with shorter overall survival in non-small cell lung cancer.Risk factors for bone metastasis in patients with primary lung cancer: study protocol for a systematic review.A phase I study of concurrent individualized, isotoxic accelerated radiotherapy and cisplatin-vinorelbine-cetuximab in patients with stage III non-small-cell lung cancer.Emerging lung cancer therapeutic targets based on the pathogenesis of bone metastasesNeoadjuvant anti-tumor vaccination prior to surgery enhances survival.Array-comparative genomic hybridization reveals loss of SOCS6 is associated with poor prognosis in primary lung squamous cell carcinoma.Systemic inflammation, nutritional status and tumor immune microenvironment determine outcome of resected non-small cell lung cancerAssociation between microsomal epoxide hydrolase 1 T113C polymorphism and susceptibility to lung cancer.MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancerGene-guided gefitinib switch maintenance therapy for patients with advanced EGFR mutation-positive non-small cell lung cancer: an economic analysisLoss of 4q21.23-22.1 is a prognostic marker for disease free and overall survival in non-small cell lung cancer.Pemetrexed induced thymidylate synthase inhibition in non-small cell lung cancer patients: a pilot study with 3'-deoxy-3'-[¹⁸F]fluorothymidine positron emission tomography.Involvement of TRPC channels in lung cancer cell differentiation and the correlation analysis in human non-small cell lung cancerWT1 promotes cell proliferation in non-small cell lung cancer cell lines through up-regulating cyclin D1 and p-pRb in vitro and in vivo.Pulmonary artery invasion, high-dose radiation, and overall survival in patients with non-small cell lung cancerOsteopontin is a prognostic biomarker in non-small cell lung cancer.LncRNA HMlincRNA717 is down-regulated in non-small cell lung cancer and associated with poor prognosis.Circulating Ang-2 mRNA expression levels: looking ahead to a new prognostic factor for NSCLC [corrected]Increased expression of microRNA-150 is associated with poor prognosis in non-small cell lung cancer.Expression of flotillin-2 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.International trial of adjuvant therapy in high risk stage I non-squamous cell carcinoma identified by a 14-gene prognostic signature
P2860
Q26801449-56AC4FC8-1EE5-46D1-A7C6-664F0933FA2AQ26826437-6342D3B7-79B3-47E2-A302-F95809EBD96FQ27309990-EE4CB637-CA8E-4369-8EAE-98F0D0646C4CQ28067610-23A27802-FA91-4E52-AB81-92B44C2915A8Q28081319-D4194ABD-4925-450D-B897-304F5EEDCB21Q28389722-5AEE6400-7390-4D2A-89DB-507DFB215881Q28540769-C6FE3F68-3ADE-4D22-A15E-AE0559743000Q30358684-FC0BC66D-8DE4-4002-81E1-B5E2250C6C8AQ30369946-73CAAE10-61DE-432D-9EC8-33B7839C4C0FQ30700527-3E12F035-8639-4C30-9E69-9B08AE7CEBB2Q33566676-E9FA8407-1CFE-4735-A8B5-D77C50B088B0Q33633724-83418469-6752-43E0-8F49-0D95AD1784DBQ33677872-A444BC65-7D76-4B42-B533-72C40113A0F3Q33733284-5CBE1D37-D28C-4316-82F4-541B1774F326Q33738926-1F2EDF8E-7B60-4AB8-AC46-AEBEA64ED28FQ33779396-67566EE9-B25C-4FD2-80ED-2189AEF25502Q33829653-34339C3B-85FF-40B5-9A43-84997AF32F4AQ33889144-80B85D74-A735-43C7-9CE7-F33FC0AA96B2Q33914079-4F73AB25-7F36-400D-AB0C-96B222EEC846Q33996458-50E5AF41-A21A-482F-9187-B264879DFB2BQ34041735-FFAC7198-1976-4EF4-8C72-13025125367AQ34101059-F68AA2BA-0B96-4E48-AC26-C35B5C49A366Q34145877-1E15D2EE-3F8A-40BB-BE08-97D42CDA20CBQ34169994-22432DF2-F92D-4B97-93B7-8CDC0B6AFCAEQ34215504-BE5CA658-0FF6-4A93-8FDE-10046F32262EQ34325979-82BB07DB-4B5D-49F5-A318-4914C56EC687Q34476639-1B224623-D85E-423B-AAF8-9E754BACFC3BQ34501770-A10C6FD5-25CB-413B-8C23-BBA4FB13FAABQ34566773-07FAD6A2-D4FD-4F32-A2E2-8D1385C1DA60Q34680492-2BDF71AD-6282-4525-A9D5-6C6619626C29Q34744444-CE6048DF-C85F-432A-A6CA-600D111B54FBQ34807837-7CF70ABA-52AD-471E-8AAB-7287BD4A673AQ34924201-280286CA-C907-4CD1-A523-6BC6E660C10BQ34937327-8C1B456B-5E48-4348-AC1F-146AC8A55406Q35038432-3944A1F8-FDB9-4687-ABBC-49FE3DE6DC6AQ35038732-790996AB-B297-48D0-B114-2C1C6DEB4549Q35108561-292BCF21-58DC-41B5-87F7-422E17CF75B1Q35144952-7E51081B-C17D-4F21-9630-953A527C708FQ35145053-35AE2314-F98B-4D0E-A6C5-445921BCFC5BQ35200413-7C204F0E-0EC8-4FB5-A2D0-B53BA2B05141
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Non-small-cell lung cancer.
@en
Non-small-cell lung cancer.
@nl
type
label
Non-small-cell lung cancer.
@en
Non-small-cell lung cancer.
@nl
prefLabel
Non-small-cell lung cancer.
@en
Non-small-cell lung cancer.
@nl
P2093
P1433
P1476
Non-small-cell lung cancer
@en
P2093
Andrew G Nicholson
David Ball
Frances A Shepherd
James R Jett
Peter Goldstraw
P304
P356
10.1016/S0140-6736(10)62101-0
P407
P577
2011-05-10T00:00:00Z